TY - JOUR
T1 - Integrated profiling of diffuse large B-cell lymphoma with 7q gain
AU - Chigrinova, Ekaterina
AU - Mian, Michael
AU - Shen, Yulei
AU - Greiner, Timothy C.
AU - Chan, Wing C.
AU - Vose, Julie M.
AU - Inghirami, Giorgio
AU - Chiappella, Annalisa
AU - Baldini, Luca
AU - Ponzoni, Maurilio
AU - Ferreri, Andrés J.M.
AU - Franceschetti, Silvia
AU - Gaidano, Gianluca
AU - Tucci, Alessandra
AU - Facchetti, Fabio
AU - Lazure, Thierry
AU - Lambotte, Olivier
AU - Montes-Moreno, Santiago
AU - Piris, Miguel A.
AU - Zucca, Emanuele
AU - Kwee, Ivo
AU - Bertoni, Francesco
PY - 2011/5
Y1 - 2011/5
N2 - To characterize diffuse large B-cell lymphoma (DLBCL) with chromosome 7 gains, we combined clinical data with genomic, RNA and miRNA profiling. Gains were associated with age >60years, female gender, a trend for higher complete response rate, lower death rate, and better overall survival in patients treated with R-CHOP. Lesions were inversely associated with bone marrow involvement and number of extra-nodal sites. Differentially expressed transcripts were enriched of genes belonging to specific pathways and miRNAs targets. MIR96, MIR182, MIR589, MIR25 were shown significantly up-regulated in 7q+ DLBCL by real-time PCR.
AB - To characterize diffuse large B-cell lymphoma (DLBCL) with chromosome 7 gains, we combined clinical data with genomic, RNA and miRNA profiling. Gains were associated with age >60years, female gender, a trend for higher complete response rate, lower death rate, and better overall survival in patients treated with R-CHOP. Lesions were inversely associated with bone marrow involvement and number of extra-nodal sites. Differentially expressed transcripts were enriched of genes belonging to specific pathways and miRNAs targets. MIR96, MIR182, MIR589, MIR25 were shown significantly up-regulated in 7q+ DLBCL by real-time PCR.
KW - Affymetrix
KW - Aggressive lymphoma
KW - Bone marrow
KW - Gain
KW - MiRNA
UR - http://www.scopus.com/inward/record.url?scp=79955035690&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79955035690&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2141.2011.08628.x
DO - 10.1111/j.1365-2141.2011.08628.x
M3 - Article
C2 - 21418177
AN - SCOPUS:79955035690
SN - 0007-1048
VL - 153
SP - 499
EP - 503
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 4
ER -